Recently, under the leadership of Executive Dean Li Xiaofei and Vice Dean Li Wenhai, Dr. Zhou Jincai and Dr. Zhai Hengyu from the Department of Thoracic Surgery at Xi'an International Medical Center Hospital have won the honor of "two battles a day". They won the "New Voice Award for Thoracic Surgery" in the "Listening to Cases Outside the Chest -2024 National Case Tour for Young and Middle aged Chinese Thoracic Surgeons"; Won the national runner up in the "Peak Surgical Target Determination and Grasping the Future 2024 National Lung Cancer Case Speech Competition".

In two peak competitions that gathered national thoracic surgery elites, our thoracic surgery team fully demonstrated superb surgical skills, profound medical expertise, and rich clinical experience. Big names lead the 'Bright Sword' national competition

The "Listening to Examples Outside the Chest" lecture tour is hosted by the China Association for Health Promotion and Education and has been held for four sessions. Over the past four years, more than 60 lectures have been conducted throughout the country, with participation from over a hundred thoracic surgery departments in hospitals.

The 2024 competition was initiated by the Guangdong Chest Disease Society, covering 21 provinces and 118 hospitals across the country, with nearly 600 experts participating. The competition is divided into three stages: regional tour, national tour, and shining examples. The top scholars in thoracic surgery form a chairman expert group for assessment and scoring. The competing teams are all well-known excellent thoracic surgery teams in China.

After three rounds of selection, the thoracic surgery team of Xi'an International Medical Center Hospital stood out from 52 teams and became one of the top five participating teams in the country, competing alongside Huashan Hospital affiliated with Fudan University, West China Hospital of Sichuan University, Union Medical College Hospital affiliated with Fujian Medical University, and Shenzhen People's Hospital.

Under the leadership of Dean Li Xiaofei and Vice Dean Li Wenhai, our hospital team, led by Dr. Zhou Jincai and Dr. Zhai Hengyu, won the "New Voice of the Chest Award" with outstanding clinical skills and case sharing through case reports, surgical presentations, virtual case on-site discussions, and other activities. On the same day, Zhou Jincai presented a speech titled "Overcoming Difficulties and Not Allowing a Potential Resectable Stage IIIB Non Small Cell Lung Cancer Case Clinical Practice and Reflection" at the Lung Cancer Case Speech Competition hosted by the Guangdong Chest Disease Society and organized by the First Affiliated Hospital of Guangzhou Medical University. With carefully prepared cases, excellent speech skills, and superb medical skills, the team received praise from experts and won the runner up.

This speech competition attracted nearly a hundred cases from dozens of domestic units to participate in the selection. The rigorous competition system places high demands on the team's diagnostic and treatment skills, as well as their understanding of relevant clinical research.

Today, opportunities and challenges coexist in the field of thoracic surgery. Under the leadership of Dean Li Xiaofei and Vice Dean Li Wenhai, the medical team of thoracic surgery has continuously made breakthroughs and achieved excellent results in national case competitions, fully reflecting the team's spirit of in-depth research and innovation in the field of thoracic surgery. It also showcased the advanced working mode, standardized diagnosis and treatment process, and good spirit of the thoracic surgery team of Xi'an International Medical Center Hospital to colleagues across the country.

At present, thoracic surgery comprehensively carries out various surgeries for lung, esophagus, and mediastinum, including thoracoscopic radical surgery for various lung cancers, complex tracheal tumor surgery, minimally invasive esophageal cancer radical surgery under full endoscopy, colon replacement esophagectomy, da Vinci robot minimally invasive lung cancer, esophageal cancer radical surgery, etc., providing patients with more systematic, comprehensive, and comprehensive treatment options and bringing hope to the future.